Skip to content
MedGenome US is now Signios Bio — same team, renewed identity.
Now offering 10x Xenium Spatial services in Foster City, CA.
Olink Reveal proteomics: 1,000+ protein biomarkers from just 4 μL of sample.
PacBio Revio long-read sequencing now available for structural variant resolution.
New: Illumina StrataMap 15x50mm spatial slide.
  • Login
  • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • All Services
    • Transcriptomics Services
    • RNA Sequencing
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • Immune Profiling
    • Premade Library Sequencing
    • Long Read Services
    • Genomics Services (WGS/WES)
    • Oncology Panel Sequencing
    • Proteomics Services
    • Epigenomics
  • Multiomics Solutions
    • Multiomics Overview
    • Academics and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical and Diagnostics Laboratories
    • Contract Research Organizations
  • Bioinformatics
    • Bioinformatics Overview
    • WES Analysis
    • RNA Analysis
    • Spatial Bioinformatics & Analysis
  • SeqProβ
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
    • FAQs
    • Referral Program
  • Company
    • About
    • News & Events
    • Grants
    • Careers
    • Certified Service Provider
    • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • All Services
    • Transcriptomics Services
    • RNA Sequencing
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • Immune Profiling
    • Premade Library Sequencing
    • Long Read Services
    • Genomics Services (WGS/WES)
    • Oncology Panel Sequencing
    • Proteomics Services
    • Epigenomics
  • Multiomics Solutions
    • Multiomics Overview
    • Multiomics – Academics and Research Institutes
    • Multiomics – Pharmaceutical & Biotechnology Companies
    • Multiomics – Clinical & Diagnostics Laboratories
    • Multiomics – Contract Research Organizations
  • Bioinformatics Solutions
    • Bioinformatics Overview
    • WES Analysis
    • RNA Analysis
    • Spatial Bioinformatics & Analysis
  • SeqProβ
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
    • FAQs
    • Referral Program
  • Company
    • About
    • News & Events
    • Grants
    • Careers
    • Certified Service Provider
    • Contact
  • Login

2018

A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers

December 26, 2018

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

October 25, 2018

A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity

September 18, 2018

A cancer vaccine approach for personalized treatment of Lynch Syndrome

August 16, 2018

Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients

July 5, 2018

Becker’s Hospital Review: Tumor microenvironment is a powerful companion diagnostic for cancer immunotherapy applications

March 15, 2018

Becker’s Hospital Review, 2018 Currently approved checkpoint inhibitors are antibodies that block the function of three key proteins expressed on the surface of T cells: CTLA-4, PD-1 and PD-L1. Under normal conditions, these proteins function as brakes to prevent immune-related toxicity from arising because of persistent T cell activity. Cancer hijacks this essential function  

Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

February 13, 2018

Ancient Human Migrations to and through Jammu Kashmir- India were not of Males Exclusively

January 24, 2018
Scientist-led NGS & multiomics services
Locations:
US:

Signios Biosciences
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

India:
MedGenome Labs Ltd.
  • Sequencing Services
  • Multiomics Solutions
  • Bioinformatics Solutions
  • Resources
  • Company
  • Login
  • Contact

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.

 

© 2026 SIGNIOSBIO. All Rights Reserved.